20
29
1
利潤將很快將股票帶到天堂嗎?
已翻譯
1
16
1
$諾和諾德 (NVO.US)$
Details:
Novo Nordisk announces a hefty $2.3 billion investment in its French facility to upsurge production of weight-loss and diabetes drugs.
The Danish pharmaceutical giant responds to skyrocketing demand, focusing on popular drugs Ozempic and Wegovy and future obesity treatments.
Europe faces a supply crisis with Ozempic due to its dual use for diabetes and 'off label' weight loss, promptin...
Details:
Novo Nordisk announces a hefty $2.3 billion investment in its French facility to upsurge production of weight-loss and diabetes drugs.
The Danish pharmaceutical giant responds to skyrocketing demand, focusing on popular drugs Ozempic and Wegovy and future obesity treatments.
Europe faces a supply crisis with Ozempic due to its dual use for diabetes and 'off label' weight loss, promptin...
9
14